Mount Sinai Hospital
Analysis
Mount Sinai Hospital is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in April 1938, 88 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Mount Sinai Hospital reported income of $3.95bn and spending of $3.94bn, spending 100% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $3.13bn to $3.95bn (+26%), an average of +6.0% a year. Over the whole period it spent 97% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Mount Sinai Hospital sits at the 100th percentile: it is one of the largest 1% in its cause. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within NY. Charities of a similar size with the same main cause include Commonspirit Health ($3.88bn), Sentara Hospitals ($3.99bn) and Texas Childrens Hospital ($3.83bn).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 0.9% and program service revenue 90% of the total. Compensation of current officers, directors and key employees was $12.1m (0.3% of expenses). Other salaries and wages came to $1.47bn. At year end it held assets of $5.78bn against liabilities of $3.47bn, net assets of $2.32bn. It reported 19,780 employees.
Income and spending
Where the income comes from
- Contributions & grants 0.9%
- Program services 90%
- Other 9.0%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Commonspirit Health | Phoenix | $3.88bn |
| Sentara Hospitals | Virginia BCH | $3.99bn |
| Texas Childrens Hospital | Bellaire | $3.83bn |
| Novant Health Inc | Winston Salem | $4.02bn |